Brickell biotech, inc. (VICL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenue from Contract with Customer, Excluding Assessed Tax

7,917

10,888

13,401

12,804

-

-

-

-

-

-

-

Contract revenue

-

-

-

-

18,860

13,304

5,846

-

-

-

-

Contract and grant revenue

-

-

-

-

-

-

-

6,176

4,223

6,249

3,692

License and royalty revenue

-

-

418

1,727

2,090

1,913

1,872

11,343

25,795

2,462

8,994

Total revenues

-

-

13,819

14,531

20,950

15,217

7,718

17,519

30,018

8,711

12,686

Operating expenses:
Research and development

20,214

12,960

14,391

10,355

11,061

11,467

14,558

17,340

17,975

19,692

23,449

Manufacturing and production

-

-

6,479

6,291

10,927

10,824

12,698

13,055

10,267

11,436

10,354

General and administrative

12,171

6,379

6,335

7,062

8,366

9,552

11,814

10,557

9,598

8,798

7,469

Total operating expenses

-

-

27,205

23,708

30,354

31,843

-

-

-

-

-

Total operating expenses

32,385

19,339

-

-

-

-

39,070

40,952

37,840

39,926

41,272

Loss from operations

-24,468

-8,451

-13,386

-9,177

-9,404

-16,626

-31,352

-23,433

-7,822

-31,215

-28,586

Investment and other income (loss), net

157

61

-

-

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

2,318

0

-

-

-

-

-

-

-

-

-

Investment and other income, net

-

-

426

204

166

134

114

534

-

-

-

Investment and other income (expense), net

-

-

-

-

-

-

-

-

539

-

-

Investment and other income, net

-

-

-

-

-

-

-

-

-

-830

-30

Interest expense

2,096

1,090

-

-

-

-

-

-

-

-

2

Liabilities, Fair Value Adjustment

-11

0

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-223

-244

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-23,900

-9,236

-12,960

-8,973

-9,238

-16,492

-31,238

-22,899

-7,283

-30,385

-28,558

Reduction of redeemable convertible preferred stock to redemption value

-10,274

5,936

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to common stockholders

-13,603

-15,172

-

-

-

-

-

-

-

-

-

Net loss per common share share attributable to common stockholders, basic (in usd per share)

-4.50

-25.85

-1.01

-0.90

-1.01

-1.86

-0.36

-0.27

-0.10

-0.51

-0.61

Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares)

3,023

586

12,888

10,019

9,175

8,879

86,840

85,966

72,031

60,084

47